Skip to main content
Log in

A lack of effect of captopril on platelet aggregation in patients with congestive heart failure

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

We have studied the acute and chronic effects of an ACE inhibitor (captopril) on platelet function and the renin-angiotensin system in patients with congestive heart failure.

Plasma concentrations of angiotensin II fell significantly after a single dose of captopril (25 mg) and during long-term treatment with captopril (2 weeks, 75 mg/day). Plasma renin activity increased significantly after both the single and repeated doses.

Captopril did not affect ADP-induced platelet aggregation or concentrations. It seems unlikely that circulating angiotensin II affects ADP-induced platelet aggregation in patients with congestive heart failure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Poplawski A (1970) The effect of angiotensin II on the platelet aggregation induced by adenosine-diphosphate, epinephrine, and thrombin. Experientia 26: 86

    Google Scholar 

  2. Ding Y, MacIntyre DE, Kenyon CJ, Semple PF (1985) Potentiation of adrenaline-induced platelet aggregation by angiotensin II. Thromb Haemost 54: 717–720

    Google Scholar 

  3. Nara Y, Kihara M, Nabika T, Mano M, Horie R, Yamori Y (1984) Dietary effect on platelet aggregation in men with and without a family history of essential hypertension. Hypertension 6: 339–343

    Google Scholar 

  4. Gow IF, Padfield PL, Reid M, Stewart S, Edwards CRW, Williams BC (1987) High sodium intake increases platelet aggregation in normal females. J Hypertens 5: s243-s246

    Google Scholar 

  5. Ferguson RK, Turini GA, Brunner GA, Gavras H, McKinstrey DN (1977) A specific orally active inhibitor of angiotensin-converting enzyme in man. Lancet I: 775–778

    Google Scholar 

  6. Someya N, Morotomi Y, Kodama K, Kida O, Higa T, Kondo K, Tanaka K (1984) Suppressive effect of captopril on platelet aggregation in essential hypertension. J Cardiovasc Pharmacol 6: 840–843

    Google Scholar 

  7. James IM, Dickenson EJ, Burgoyne W, Jeremy JY, Barradas MA, Mikhailidis DP, Dandona P (1988) Treatment of hypertension with captopril: preservation of regional blood flow and reduced platelet aggregation. J Hum Hypertens 2: 21–25

    Google Scholar 

  8. Erdos EG (1975) Angiotensin I converting enzyme. Circ Res 36: 247–255

    Google Scholar 

  9. McGiff JC, Terragno NA, Malik KU, Lonigro AJ (1972) Release of a prostaglandin E-like substance from canine kidney by bradykinin. Circ Res 31: 36–43

    Google Scholar 

  10. Szczeklik A, Gryglewski RJ, Nizankowski R, Musial J, Pieton R, Mruk J (1978) Circulatory and anti-platelet effects of intravenous prostacyclin in healthy men. Pharmacol Res Commun 10: 545–556

    Google Scholar 

  11. Fitzgerald GA, Friedman LA, Miyamori I, O'Grady J, Lewis PJ (1979) A double-blind placebo-controlled crossover study of prostacyclin in man. Life Sci 25: 665–672

    Google Scholar 

  12. Schwartz MB, Hawiger J, Timmons S, Friesinger GC (1980) Platelet aggregates in ischaemic heart disease. Thromb Haemost 43: 185–188

    Google Scholar 

  13. De Boer AC, Turpie AGG, Butt RW, Johnston RV, Genton E (1982) Platelet release and thromboxane synthesis in symptomatic coronary artery disease. Circulation 66: 3270–3333

    Google Scholar 

  14. Parbtani A, Frampton G, Cameron JS (1980) Measurement of platelet release substances in glomerulonephritis: a comparison of beta-thromboglobulin (β-TG), platelet factor 4 (PF4), and serotonin assays. Thromb Res 19: 177–189

    Google Scholar 

  15. Shaw TRD, Duncan FM, Williams BC, Crichton E, Thompson SA, Davis JRE, Rademaker M, Edwards CRW (1985) Plasma free captopril concentrations during short and long-term treatment with oral captopril for heart failure. Br Heart J 54: 160–165

    Google Scholar 

  16. Gow IF, Corrie JET, Williams BC, Edwards CRW (1987) Development and validation of an improved radioimmunoassay for serotonin in platelet-rich plasma. Clin Chim Acta 162: 175–188

    Google Scholar 

  17. Born GVR (1985) Adenosine diphosphate as a mediator of platelet aggregation in vivio. Adv Exp Med Biol 192: 299–409

    Google Scholar 

  18. Haber E, Koerner T, Page LB, Kliman B, Purnode A (1969) Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin in normal human subjects. J Clin Endocrinol Metab 29: 1349–1355

    Google Scholar 

  19. Düsterdieck G, McElwee G (1971) Estimation of angiotensin II concentrations in human plasma by radioimmunoassay. Eur J Clin Invest 2: 32–38

    Google Scholar 

  20. Morton JJ, Webb DJ (1985) Measurement of plasma angiotensin II. Clin Sci 68: 483–484

    Google Scholar 

  21. Ding Y, Kenyon CJ, Semple PF (1985) Regulation of platelet receptors for angiotensin II in man. J Hypertens 3: 209–212

    Google Scholar 

  22. Kondowe GB, Kelly JG, Copeland S, Johnston GD (1987) The effect of chronic captopril therapy on platelet angiotensin II receptor density and vascular responsiveness to angiotensin II infusion. Eur J Clin Pharmacol 31: 525–530

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gow, I.F., Flapan, A.D., Morris, M. et al. A lack of effect of captopril on platelet aggregation in patients with congestive heart failure. Eur J Clin Pharmacol 41, 47–49 (1991). https://doi.org/10.1007/BF00280105

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00280105

Key words

Navigation